ValorQ4, 24Q1, 25Q2, 25TTMGastos comerciales, generales y administrativos265.13 M259.19 M278.4 M1.05 BInvestigación y desarrollo86.44 M87.32 M90.97 M348.68 MBeneficio operativo454.54 M446.54 M491.66 M1.82 BTotal de ingresos no operativos3.51 M256 K4.49 M-317 KGastos por intereses, netos de intereses capitalizados————Ingresos no operativos, una vez deducidos los gastos por intereses4.49 M4.09 M9.77 M13.84 MIngresos/gastos extraordinarios-979 K-3.84 M-5.28 M-14.15 MBeneficio antes de impuestos458.05 M446.79 M496.15 M1.82 BParticipación en los beneficios1.27 M1.49 M1.51 M4.61 MImpuestos78.35 M98.26 M103.56 M332.81 MParticipación minoritaria————Otros ingresos/gastos después de impuestos————Beneficio neto antes de actividades interrumpidas379.7 M348.54 M392.59 M1.49 BOperaciones suspendidas————Beneficio neto379.7 M348.54 M392.59 M1.49 BAjuste por dilución————Dividendos de las acciones preferentes————Beneficio neto diluido atribuible a los accionistas379.7 M348.54 M392.59 M1.49 BBeneficio básico por acción2.592.382.6910.15Beneficio por acción diluido2.582.372.6810.11Número medio de acciones ordinarias146.72 M146.18 M145.84 M585.46 MAcciones diluidas147.34 M146.9 M146.37 M587.83 MEBITDA518.17 M494.24 M541.54 M2.02 BEBIT454.54 M446.54 M491.66 M1.82 BCosto de los ingresos527.93 M514.76 M544.08 M2.11 BOtros costes de producción518.56 M506.94 M536.28 M2.08 BAmortización y depreciación (flujo de caja)63.63 M47.7 M49.88 M204.89 M
ResMed Inc
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024.